Welcome to Paid Research Studies




  • Condition:   Marfan Syndrome
    Intervention:   Device: Rehabilitation program
    Sponsor:   University Hospital, Toulouse
    Recruiting

  • Condition:   Marfan Syndrome
    Intervention:   Behavioral: Exercise
    Sponsors:   Stanford University;   Midwestern University
    Recruiting

  • Condition:   Marfan Syndrome
    Intervention:   Other: Tele-Clinic Visits Using Parent-Acquired Echos
    Sponsor:   Stanford University
    Recruiting

  • Conditions:   Sleep-disordered Breathing;   Snoring
    Intervention:   Device: CPAP
    Sponsors:   Johns Hopkins University;   The Marfan Foundation;   National Institutes of Health (NIH)
    Recruiting

  • Conditions:   Aortopathies;   Thoracic Aortic Aneurysm;   Aortic Valve Disease;   Thoracic Aortic Disease;   Thoracic Aortic Dissection;   Thoracic Aortic Rupture;   Ascending Aortic Disease;   Descending Aortic Disease;   Ascending Aortic Aneurysm;   Descending Aortic Aneurysm;   Marfan Syndrome;   Loeys-Dietz Syndrome;   Ehlers-Danlos Syndrome;   Shprintzen-Goldberg Syndrome;   Turner Syndrome;   PHACE Syndrome;   Autosomal Recessive Cutis Laxa;   Congenital Contractural Arachnodactyly;   Arterial Tortuosity Syndrome
    Intervention:  
    Sponsor:   Indiana University
    Recruiting

  • Condition:   22q11.2 Deletion Syndrome
    Intervention:   Behavioral: Cognitive remediation program
    Sponsor:   Hôpital le Vinatier
    Recruiting

  • Conditions:   Complete DiGeorge Anomaly;   DiGeorge Syndrome;   DiGeorge Anomaly;   Complete DiGeorge Syndrome
    Interventions:   Biological: Thymus Tissue for Transplantation;   Procedure: Blood Draw;   Drug: Rabbit anti-thymocyte globulin;   Drug: Cyclosporine;   Drug: Tacrolimus;   Drug: Methylprednisolone or Prednisolone;   Drug: Basiliximab;   Drug: Mycophenolate mofetil
    Sponsors:   M. Louise Markert;   National Institutes of Health (NIH);   National Institute of Allergy and Infectious Diseases (NIAID);   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);   Enzyvant Therapeutics GmbH
    Available

  • Conditions:   Velocardiofacial Syndrome;   Williams Syndrome;   Fragile X Syndrome
    Intervention:   Drug: methylphenidate, fluoxetin, risperidone
    Sponsor:   The Chaim Sheba Medical Center
    Recruiting